Table 2.
Immunostaining of CD40 in ovarian carcinoma TAM: correlation with clinicopathological parameters
| Factors | Number | Staining score | P value |
|---|---|---|---|
| Age | |||
| ≤40 years | 37 | 3.32 ± 2.63 | 0.63 |
| 41–59 years | 115 | 3.29 ± 2.85 | |
| ≥60 years | 36 | 2.81 ± 2.84 | |
| Differentiation | |||
| Well | 21 | 2.81 ± 2.63 | 0.007 |
| Moderate | 76 | 2.64 ± 2.63 | |
| Poor | 70 | 4.04 ± 2.81 | |
| T stage | |||
| T1 | 84 | 3.19 ± 2.76 | 0.38 |
| T2 | 34 | 3.59 ± 3.12 | |
| T3 | 54 | 2.63 ± 2.43 | |
| T4 | 15 | 3.43 ± 3.40 | |
| N (lymph node metastasis) | |||
| N0 | 15 | 2.80 ± 3.21 | 0.85 |
| N1 | 127 | 3.16 ± 2.75 | |
| N2 | 46 | 3.26 ± 2.86 | |
| Clinical stage | |||
| I | 88 | 3.34 ± 2.80 | 0.59 |
| II | 26 | 3.23 ± 2.98 | |
| III | 54 | 3.09 ± 2.74 | |
| IV | 16 | 2.31 ± 2.49 | |